SEC Comment Letter for BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308) (ONC) — Aug 16, 2017
BeOne Medicines Ltd. (ONC, BEIGF) (CIK 0001651308)
Date: Aug. 16, 2017 · CIK: 0001651308 · Accession: 0000000000-17-029040
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-37686
Letter
Mail Stop 4546 August 16 , 2017 VIA E -mail John V. Oyler Chief Executive Officer and Chairman BeiGene, Ltd. c/o Mourant Ozannes Corporate Services (Cayman) Limited 94 Solaris Avenue, Camana Bay Grand Cayman Cayman Islands
Re: BeiGene, Ltd. Form 10 -K Filed March 22, 2017 File No. 001-37686
Dear Mr. Oyler :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4546 August 16 , 2017 VIA E -mail John V. Oyler Chief Executive Officer and Chairman BeiGene, Ltd. c/o Mourant Ozannes Corporate Services (Cayman) Limited 94 Solaris Avenue, Camana Bay Grand Cayman Cayman Islands Re: BeiGene, Ltd. Form 10 -K Filed March 22, 2017 File No. 001-37686 Dear Mr. Oyler : We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare & Insurance